市場調査レポート

商品コード

1140005

心臓リハビリテーション市場：製品タイプ別、疾患タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Cardiac Rehabilitation Market By Product, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年07月01日 | 発行: Allied Market Research

| ページ情報: 英文 269 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 900,412円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の心臓リハビリテーション市場は、2021年に19億7110万米ドル、2031年には32億4138万米ドルに達し、2022年から2031年にかけてCAGR5.1%を記録すると予測されています。

心臓リハビリテーションは、患者の心臓血管の健康を改善するために設計された、医学的に管理されたプログラムです。外来患者向けにカスタマイズされた運動プログラムです。心臓リハビリテーションには、心臓病のリスクを軽減するための運動トレーニングが含まれることが多いです。心臓発作、心不全、冠動脈バイパス移植、心臓弁修復置換のリスクが高い患者さんにとって重要です。心臓リハビリテーションプログラムは、心血管系疾患による心理的ストレスを制限し、心血管系機能を改善して、患者が可能な限り最高の生活の質を達成できるようにすることを目的としています。心臓リハビリテーションでは、心臓疾患に関する日常生活で必要とされる情報を提供します。これらの機器/装置は心臓血管手術や心臓発作からの回復に役立ちます。

心臓リハビリ市場の成長を促進する主な要因は、心血管疾患の症例の増加と、時間、距離、コストの障壁を最小限に抑えるために、遠隔心臓リハビリテーションの採用が増加したことです。これに加え、心臓リハビリ機器の技術的進歩の多さ、これらの治療法の採用率の増加、心臓関連疾患の早期介入と一次予防の重視の高まりなど、多くの要因が市場成長の原動力になっています。さらに、連続的な患者の監視のためのCOVID-19パンデミックの間に指先の酸化計デバイスの需要と採用の上昇と多数の主要なプレーヤーによる新しい指先のパルスオキシメーターの発売は、市場の成長を促進する主な要因となっています。さらに、経済協力開発機構によると、2018年には、ドイツで合計45,307件の冠動脈バイパス移植術が実施されました。したがって、緊急手術の発生率の急増と手術後の心臓リハビリテーションデバイスの広範な使用は、心臓リハビリテーション市場の成長を推進します。

また、製薬・医療機器産業の開拓や医療費の改善も、心臓リハビリテーション市場の成長を後押しすると予想されます。例えば、2020年1月、オムロン株式会社は、HeartGuideデバイスを発売しました。このデバイスは、血圧をモニターするウェアラブル心臓リハビリテーション製品です。これにより、いつでもどこでも血圧をモニターできるようになっています。また、日中の血圧の変動を把握し、高血圧のコントロールに役立てることができます。定期的な血圧の自己管理は、心疾患のリスクを大幅に軽減することができます。さらに、米国での高い需要と予約販売により、オムロンは80件以上の特許を申請し、精度と信頼性を保証する腕時計のデザインにHeartGuideを組み込んで開発しました。このように、革新的な製品ラインの存在が、心臓リハビリテーション市場の成長を後押ししています。

さらに、老年人口の増加と心血管疾患の負担の増加は、人々の間で心臓リハビリテーションに関する意識の上昇につながる、これは市場の成長を推進しています。さらに、世界保健機関によると、2019年には1790万人が心血管疾患により死亡すると推定されています。したがって、心血管疾患の負担の急増と心不全の割合の増加は、心臓リハビリテーションの需要を押し上げると予測されます。さらに、製品承認の数の増加は、予測期間中に世界市場の拡大のために報酬の機会を提供することが期待されます。座りっぱなしのライフスタイルは、糖尿病や心血管障害など、多くの疾患を引き起こしやすくします。高血圧と糖尿病は、心不全の増加の原因となっている2つの主な要因です。この病気は入院率が高く、心拍数や血圧のモニター装置を頻繁に使用するため、多額の費用がかかります。このように、慢性疾患の増加に伴う手術件数の増加により、心臓リハビリテーション製品の採用率が高まり、市場の成長率が高まると予想されます。

しかし、心臓リハビリ製品の高コスト、限られた資金、熟練した専門家の不足が市場成長を阻害する要因になると予測されます。現在、人々の健康に対する意識が高まり、健康状態の維持や家庭用フィットネス機器の使用率上昇につながることが期待されています。このため、多くの主要企業が新興市場に参入し、心臓リハビリテーション市場に有利な成長機会を提供しています。

概要
- 市場規模および予測
エリプティカルトレーナー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
スタビライゼーションボール
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
トレッドミル
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
心拍計
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
血圧計
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ローワー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第5章心臓リハビリテーション市場：疾患タイプ別

概要
- 市場規模および予測
経皮的冠動脈インターベンション
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別分析
心筋梗塞（Myocardial Infarction
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
冠動脈：バイパスグラフト術
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
冠動脈疾患
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章心臓リハビリテーション市場：エンドユーザー別

概要
- 市場規模・予測
リハビリセンター
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別
病院
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
診療所
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章心臓リハビリテーション市場：地域別

概要
- 市場規模・予測
北米
- 主要動向と機会
- 北米市場規模・予測：製品別
- 北米市場規模・予測：疾患タイプ別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州市場規模・予測：製品別
- 欧州市場規模・予測：疾患タイプ別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他の欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：製品別
- アジア太平洋地域の市場規模・予測：疾患タイプ別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - オーストラリア
  - インド
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：製品別
- LAMEAの市場規模・予測：疾患タイプ別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ共和国
  - LAMEAの残りの地域

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

Halma plc.
Life Fitness
GE Healthcare
Smiths Group
Koninklijke Philips N.V.
Omron Corporation
Technogym
Core Health & Fitness, LLC
Baxter
Johnson Health Tech.

図表

LIST OF TABLES

TABLE 1. GLOBAL CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. CARDIAC REHABILITATION MARKET SIZE, FOR ELLIPTICAL TRAINER, BY REGION, 2021-2031 ($MILLION)
TABLE 3. CARDIAC REHABILITATION MARKET FOR ELLIPTICAL TRAINER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. CARDIAC REHABILITATION MARKET SIZE, FOR STABILIZATION BALL, BY REGION, 2021-2031 ($MILLION)
TABLE 5. CARDIAC REHABILITATION MARKET FOR STABILIZATION BALL BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. CARDIAC REHABILITATION MARKET SIZE, FOR TREADMILL, BY REGION, 2021-2031 ($MILLION)
TABLE 7. CARDIAC REHABILITATION MARKET FOR TREADMILL BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. CARDIAC REHABILITATION MARKET SIZE, FOR HEART RATE MONITOR, BY REGION, 2021-2031 ($MILLION)
TABLE 9. CARDIAC REHABILITATION MARKET FOR HEART RATE MONITOR BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. CARDIAC REHABILITATION MARKET SIZE, FOR BLOOD PRESSURE MONITOR, BY REGION, 2021-2031 ($MILLION)
TABLE 11. CARDIAC REHABILITATION MARKET FOR BLOOD PRESSURE MONITOR BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. CARDIAC REHABILITATION MARKET SIZE, FOR ROWER, BY REGION, 2021-2031 ($MILLION)
TABLE 13. CARDIAC REHABILITATION MARKET FOR ROWER BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. CARDIAC REHABILITATION MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. CARDIAC REHABILITATION MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. GLOBAL CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 17. CARDIAC REHABILITATION MARKET SIZE, FOR PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2021-2031 ($MILLION)
TABLE 18. CARDIAC REHABILITATION MARKET FOR PERCUTANEOUS CORONARY INTERVENTION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. CARDIAC REHABILITATION MARKET SIZE, FOR MYOCARDIAL INFARCTION, BY REGION, 2021-2031 ($MILLION)
TABLE 20. CARDIAC REHABILITATION MARKET FOR MYOCARDIAL INFARCTION BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. CARDIAC REHABILITATION MARKET SIZE, FOR CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2021-2031 ($MILLION)
TABLE 22. CARDIAC REHABILITATION MARKET FOR CORONARY ARTERY BYPASS GRAFTING BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. CARDIAC REHABILITATION MARKET SIZE, FOR CORONARY ARTERY DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 24. CARDIAC REHABILITATION MARKET FOR CORONARY ARTERY DISEASE BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. CARDIAC REHABILITATION MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 26. CARDIAC REHABILITATION MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. GLOBAL CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. CARDIAC REHABILITATION MARKET SIZE, FOR REHAB CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. CARDIAC REHABILITATION MARKET FOR REHAB CENTERS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. CARDIAC REHABILITATION MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. CARDIAC REHABILITATION MARKET FOR HOSPITALS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. CARDIAC REHABILITATION MARKET SIZE, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 33. CARDIAC REHABILITATION MARKET FOR CLINICS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. CARDIAC REHABILITATION MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 35. CARDIAC REHABILITATION MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. CARDIAC REHABILITATION MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 37. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 38. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 39. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 40. NORTH AMERICA CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. U.S. CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. U.S. CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 43. U.S. CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. CANADA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 45. CANADA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 46. CANADA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. MEXICO CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 48. MEXICO CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 49. MEXICO CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. EUROPE CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 51. EUROPE CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 52. EUROPE CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. EUROPE CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. GERMANY CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. GERMANY CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 56. GERMANY CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. FRANCE CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. FRANCE CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 59. FRANCE CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. U.K. CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. U.K. CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 62. U.K. CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. ITALY CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 64. ITALY CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 65. ITALY CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. SPAIN CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 67. SPAIN CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 68. SPAIN CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. REST OF EUROPE CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 70. REST OF EUROPE CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 71. REST OF EUROPE CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 74. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 76. JAPAN CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. JAPAN CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 78. JAPAN CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. CHINA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. CHINA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 81. CHINA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. AUSTRALIA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. AUSTRALIA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 84. AUSTRALIA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. INDIA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 86. INDIA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 87. INDIA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. SOUTH KOREA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. SOUTH KOREA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 90. SOUTH KOREA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 94. LAMEA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 95. LAMEA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 96. LAMEA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 97. LAMEA CARDIAC REHABILITATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 98. BRAZIL CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. BRAZIL CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 100. BRAZIL CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. SAUDI ARABIA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 103. SAUDI ARABIA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 104. SOUTH AFRICA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 105. SOUTH AFRICA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 106. SOUTH AFRICA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 107. REST OF LAMEA CARDIAC REHABILITATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 108. REST OF LAMEA CARDIAC REHABILITATION MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 109. REST OF LAMEA CARDIAC REHABILITATION MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 110.HALMA PLC.: COMPANY SNAPSHOT
TABLE 111.HALMA PLC.: OPERATING SEGMENTS
TABLE 112.HALMA PLC.: PRODUCT PORTFOLIO
TABLE 113.HALMA PLC.: NET SALES,
TABLE 114.HALMA PLC.: KEY STRATERGIES
TABLE 115.LIFE FITNESS: COMPANY SNAPSHOT
TABLE 116.LIFE FITNESS: OPERATING SEGMENTS
TABLE 117.LIFE FITNESS: PRODUCT PORTFOLIO
TABLE 118.LIFE FITNESS: NET SALES,
TABLE 119.LIFE FITNESS: KEY STRATERGIES
TABLE 120.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 121.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 122.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 123.GE HEALTHCARE: NET SALES,
TABLE 124.GE HEALTHCARE: KEY STRATERGIES
TABLE 125.SMITHS GROUP: COMPANY SNAPSHOT
TABLE 126.SMITHS GROUP: OPERATING SEGMENTS
TABLE 127.SMITHS GROUP: PRODUCT PORTFOLIO
TABLE 128.SMITHS GROUP: NET SALES,
TABLE 129.SMITHS GROUP: KEY STRATERGIES
TABLE 130.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 131.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 132.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 133.KONINKLIJKE PHILIPS N.V.: NET SALES,
TABLE 134.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
TABLE 135.OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 136.OMRON CORPORATION: OPERATING SEGMENTS
TABLE 137.OMRON CORPORATION: PRODUCT PORTFOLIO
TABLE 138.OMRON CORPORATION: NET SALES,
TABLE 139.OMRON CORPORATION: KEY STRATERGIES
TABLE 140.TECHNOGYM: COMPANY SNAPSHOT
TABLE 141.TECHNOGYM: OPERATING SEGMENTS
TABLE 142.TECHNOGYM: PRODUCT PORTFOLIO
TABLE 143.TECHNOGYM: NET SALES,
TABLE 144.TECHNOGYM: KEY STRATERGIES
TABLE 145.CORE HEALTH & FITNESS, LLC: COMPANY SNAPSHOT
TABLE 146.CORE HEALTH & FITNESS, LLC: OPERATING SEGMENTS
TABLE 147.CORE HEALTH & FITNESS, LLC: PRODUCT PORTFOLIO
TABLE 148.CORE HEALTH & FITNESS, LLC: NET SALES,
TABLE 149.CORE HEALTH & FITNESS, LLC: KEY STRATERGIES
TABLE 150.BAXTER: COMPANY SNAPSHOT
TABLE 151.BAXTER: OPERATING SEGMENTS
TABLE 152.BAXTER: PRODUCT PORTFOLIO
TABLE 153.BAXTER: NET SALES,
TABLE 154.BAXTER: KEY STRATERGIES
TABLE 155.JOHNSON HEALTH TECH.: COMPANY SNAPSHOT
TABLE 156.JOHNSON HEALTH TECH.: OPERATING SEGMENTS
TABLE 157.JOHNSON HEALTH TECH.: PRODUCT PORTFOLIO
TABLE 158.JOHNSON HEALTH TECH.: NET SALES,
TABLE 159.JOHNSON HEALTH TECH.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.CARDIAC REHABILITATION MARKET SEGMENTATION
FIGURE 2.CARDIAC REHABILITATION MARKET,2021-2031
FIGURE 3.CARDIAC REHABILITATION MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CARDIAC REHABILITATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.CARDIAC REHABILITATION MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ELLIPTICAL TRAINER CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF STABILIZATION BALL CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF TREADMILL CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HEART RATE MONITOR CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF BLOOD PRESSURE MONITOR CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ROWER CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 20.CARDIAC REHABILITATION MARKET,BY DISEASE TYPE,2021(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF PERCUTANEOUS CORONARY INTERVENTION CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF MYOCARDIAL INFARCTION CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY BYPASS GRAFTING CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF CORONARY ARTERY DISEASE CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 26.CARDIAC REHABILITATION MARKET,BY END USER,2021(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF REHAB CENTERS CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CLINICS CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS CARDIAC REHABILITATION MARKET,2021-2031(%)
FIGURE 31.CARDIAC REHABILITATION MARKET BY REGION,2021
FIGURE 32.U.S. CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 33.CANADA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 34.MEXICO CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 35.GERMANY CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 36.FRANCE CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 37.U.K. CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 38.ITALY CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 39.SPAIN CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 40.REST OF EUROPE CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 41.JAPAN CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 42.CHINA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 43.AUSTRALIA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 44.INDIA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 45.SOUTH KOREA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 46.REST OF ASIA-PACIFIC CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 47.BRAZIL CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 48.SAUDI ARABIA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 49.SOUTH AFRICA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 50.REST OF LAMEA CARDIAC REHABILITATION MARKET,2021-2031($MILLION)
FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 54.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 55.COMPETITIVE DASHBOARD
FIGURE 56.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 57.HALMA PLC..: NET SALES ,($MILLION)
FIGURE 58.LIFE FITNESS.: NET SALES ,($MILLION)
FIGURE 59.GE HEALTHCARE.: NET SALES ,($MILLION)
FIGURE 60.SMITHS GROUP.: NET SALES ,($MILLION)
FIGURE 61.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
FIGURE 62.OMRON CORPORATION.: NET SALES ,($MILLION)
FIGURE 63.TECHNOGYM.: NET SALES ,($MILLION)
FIGURE 64.CORE HEALTH & FITNESS, LLC.: NET SALES ,($MILLION)
FIGURE 65.BAXTER.: NET SALES ,($MILLION)
FIGURE 66.JOHNSON HEALTH TECH..: NET SALES ,($MILLION)

Product Code: A11270

The global cardiac rehabilitation market was valued at $1,971.1 million in 2021 and is projected to reach $3,241.38 million by 2031 registering a CAGR of 5.1% from 2022 to 2031.

Cardiac rehab is a medically supervised program which is designed to improve patient's cardiovascular health. It is customized outpatient program of exercise. Cardiac rehabilitation often involves exercise training to reduce heart disease risk. It is important for patients who are at higher risk of heart attack, heart failure, coronary artery bypass graft, and heart valve repair replacement. Cardiac rehabilitation program aims to limit the psychological stresses of cardiovascular disease and improve cardiovascular function to help patients achieve their highest quality of life possible. Cardiac rehab gives the information which is required in everyday life about heart disorders. These equipment/devices help recover from cardiovascular surgery and heart attack.

The main factors that foster the growth of the cardiac rehabilitation market are rise in cases of cardiovascular disease, and increase in adoption of tele-cardiac rehabilitation to minimize barriers for time, distance and cost. Along with this, a number of factors such as a large number of technological advancements in cardiac rehab devices, increase in adoption rate of these therapies, and rise in emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market growth. Moreover, rise in demand and adoption of finger-tip oximeter devices during the COVID-19 pandemic for continuous patient monitoring and launch of new finger-tip pulse oximeter by large number of key players are the major factors driving the market growth. Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive uses of cardiac rehabilitation devices post-surgery propel the growth of the cardiac rehabilitation market.

Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the cardiac rehabilitation market. For instance, in January 2020, Omron Corporation has launched HeartGuide device. This device is a wearable cardiac rehabilitation product that monitor blood pressure. It enabled people to monitor their blood pressure wherever and whenever they want. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the cardiac rehabilitation market.

Furthermore, rise in geriatric population and increase in burden of cardiovascular diseases lead to rise in awareness regarding cardiac rehabilitation among people, which drive the growth of the market. Moreover, according to World Health Organization, 17.9 million people were estimated to die from cardiovascular disease in 2019. Thus, upsurge in burden of cardiovascular diseases and increased rate of heart failure are anticipated to boost the demand for cardiac rehabilitation. Furthermore, rise in number of product approvals is expected to provide remunerative opportunities for the expansion of the global market during the forecast period. Sedentary lifestyle makes people susceptible to having many disorders such as diabetes, and cardiovascular disorders. High blood pressure and diabetes are the two main factors responsible for the rise in number of heart failures. This disease is associated with high hospitalization rate and substantial cost due to frequent use of heart rate and blood pressure monitor devices. Thus, an increase in number of surgeries due to rise in cases of chronic diseases is expected to increase the adoption rate of cardiac rehabilitation products and increase the growth of the market.

However, high costs of cardiac rehabilitation products, limited availability of funds, and dearth of skilled professionals are the factors projected to impede the market growth. Presently, there is an increase in awareness regarding health among people, which, in turn, compels them to maintain their health condition and leads to rise in usage of home fitness devices. This has encouraged many key players to enter emerging market, thus offering lucrative growth opportunities in the cardiac rehabilitation market.

For the purpose of analysis cardiac rehabilitation market is studied across by product type, disease type, and end user. On the basis of product type the market is segmented into elliptical trainer, stabilization ball, treadmills, heart rate monitor, blood pressure monitor, rower, and others. By disease type, the market is divided into percutaneous coronary intervention, myocardial infraction, coronary artery bypass grafting, coronary artery disease, and others. By end user, it is categorized into rehab centers, hospitals, clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players mentioned in the report are Baxter International Inc., Core Health & Fitness, LLC, GE Healthcare, Halma Plc, Johnson Health Tech, Koninklijke Philips N.V, Life Fitness, Omron Corporation, Smith Group, and Technogym.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiac rehabilitation market analysis from 2021 to 2031 to identify the prevailing cardiac rehabilitation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cardiac rehabilitation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cardiac rehabilitation market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Elliptical Trainer
Stabilization ball
Treadmill
Heart rate monitor
Blood pressure monitor
Rower
Others

By Disease Type

Percutaneous Coronary Intervention
Myocardial Infarction
Coronary Artery Bypass Grafting
Coronary Artery Disease
Others

By End User

Rehab Centers
Hospitals
Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Halma plc.
- Life Fitness
- GE Healthcare
- Smiths Group
- Koninklijke Philips N.V.
- Omron Corporation
- Technogym
- Core Health & Fitness, LLC
- Baxter
- Johnson Health Tech.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CARDIAC REHABILITATION MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Elliptical Trainer
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Stabilization ball
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Treadmill
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
4.5 Heart rate monitor
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
4.6 Blood pressure monitor
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
4.7 Rower
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
4.8 Others
- 4.8.1 Key market trends, growth factors and opportunities
- 4.8.2 Market size and forecast, by region
- 4.8.3 Market analysis by country

CHAPTER 5: CARDIAC REHABILITATION MARKET, BY DISEASE TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Percutaneous Coronary Intervention
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Myocardial Infarction
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Coronary Artery Bypass Grafting
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Coronary Artery Disease
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country

CHAPTER 6: CARDIAC REHABILITATION MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Rehab Centers
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Clinics
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country

CHAPTER 7: CARDIAC REHABILITATION MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Disease Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product
  - 7.2.5.1.2 Market size and forecast, by Disease Type
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product
  - 7.2.5.2.2 Market size and forecast, by Disease Type
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product
  - 7.2.5.3.2 Market size and forecast, by Disease Type
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Disease Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product
  - 7.3.5.1.2 Market size and forecast, by Disease Type
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Product
  - 7.3.5.2.2 Market size and forecast, by Disease Type
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Product
  - 7.3.5.3.2 Market size and forecast, by Disease Type
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Product
  - 7.3.5.4.2 Market size and forecast, by Disease Type
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Product
  - 7.3.5.5.2 Market size and forecast, by Disease Type
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product
  - 7.3.5.6.2 Market size and forecast, by Disease Type
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Disease Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Product
  - 7.4.5.1.2 Market size and forecast, by Disease Type
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Product
  - 7.4.5.2.2 Market size and forecast, by Disease Type
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Product
  - 7.4.5.3.2 Market size and forecast, by Disease Type
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Product
  - 7.4.5.4.2 Market size and forecast, by Disease Type
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Product
  - 7.4.5.5.2 Market size and forecast, by Disease Type
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Product
  - 7.4.5.6.2 Market size and forecast, by Disease Type
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Disease Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product
  - 7.5.5.1.2 Market size and forecast, by Disease Type
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product
  - 7.5.5.2.2 Market size and forecast, by Disease Type
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Product
  - 7.5.5.3.2 Market size and forecast, by Disease Type
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Product
  - 7.5.5.4.2 Market size and forecast, by Disease Type
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Halma plc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Life Fitness
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 GE Healthcare
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Smiths Group
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Koninklijke Philips N.V.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Omron Corporation
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Technogym
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Core Health & Fitness, LLC
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Baxter
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Johnson Health Tech.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

心臓リハビリテーション市場：製品タイプ別、疾患タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Cardiac Rehabilitation Market By Product, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章心臓リハビリテーション市場：製品別

第5章心臓リハビリテーション市場：疾患タイプ別

第6章心臓リハビリテーション市場：エンドユーザー別

第7章心臓リハビリテーション市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: CARDIAC REHABILITATION MARKET, BY PRODUCT

CHAPTER 5: CARDIAC REHABILITATION MARKET, BY DISEASE TYPE

CHAPTER 6: CARDIAC REHABILITATION MARKET, BY END USER

CHAPTER 7: CARDIAC REHABILITATION MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

心臓リハビリテーション市場：製品タイプ別、疾患タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Cardiac Rehabilitation Market By Product, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 心臓リハビリテーション市場：製品別

第5章 心臓リハビリテーション市場：疾患タイプ別

第6章 心臓リハビリテーション市場：エンドユーザー別

第7章 心臓リハビリテーション市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: CARDIAC REHABILITATION MARKET, BY PRODUCT

CHAPTER 5: CARDIAC REHABILITATION MARKET, BY DISEASE TYPE

CHAPTER 6: CARDIAC REHABILITATION MARKET, BY END USER

CHAPTER 7: CARDIAC REHABILITATION MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章心臓リハビリテーション市場：製品別

第5章心臓リハビリテーション市場：疾患タイプ別

第6章心臓リハビリテーション市場：エンドユーザー別

第7章心臓リハビリテーション市場：地域別

第8章企業情勢

第9章企業プロファイル